Genome-Wide Transcriptomic Analysis of Intestinal Mucosa in Celiac Disease Patients on a Gluten-Free Diet and Postgluten Challenge.
Celiac Disease
Gluten Challenge
Gluten-Free Diet
Morphometry
RNA-Seq
Journal
Cellular and molecular gastroenterology and hepatology
ISSN: 2352-345X
Titre abrégé: Cell Mol Gastroenterol Hepatol
Pays: United States
ID NLM: 101648302
Informations de publication
Date de publication:
2021
2021
Historique:
received:
07
05
2020
revised:
24
07
2020
accepted:
24
07
2020
pubmed:
4
8
2020
medline:
21
12
2021
entrez:
4
8
2020
Statut:
ppublish
Résumé
Gluten challenge studies are instrumental in understanding the pathophysiology of celiac disease. Our aims in this study were to reveal early gluten-induced transcriptomic changes in duodenal biopsies and to find tools for clinics. Duodenal biopsies were collected from 15 celiac disease patients on a strict long-term gluten-free diet (GFD) prior to and post a gluten challenge (PGC) and from 6 healthy control individuals (DC). Biopsy RNA was subjected to genome-wide 3' RNA-Seq. Sequencing data was used to determine the differences between the three groups and was compared to sequencing data from the public repositories. The biopsies underwent morphometric analyses. In DC vs. GFD group comparisons, 167 differentially expressed genes were identified with 117 genes downregulated and 50 genes upregulated. In PGC vs. GFD group comparisons, 417 differentially expressed genes were identified with 195 genes downregulated and 222 genes upregulated. Celiac disease patients on a GFD were not "healthy". In particular, genes encoding proteins for transporting small molecules were expressed less. In addition to the activation of immune response genes, a gluten challenge induced hyperactive intestinal wnt-signaling and consequent immature crypt gene expression resulting in less differentiated epithelium. Biopsy gene expression in response to a gluten challenge correlated with the extent of the histological damage. Regression models using only four gene transcripts described 97.2% of the mucosal morphology and 98.0% of the inflammatory changes observed. Our gluten challenge trial design provided an opportunity to study the transition from health to disease. The results show that even on a strict GFD, despite being deemed healthy, patients reveal patterns of ongoing disease. Here, a transcriptomic regression model estimating the extent of gluten-induced duodenal mucosal injury is presented.
Sections du résumé
BACKGROUND & AIMS
Gluten challenge studies are instrumental in understanding the pathophysiology of celiac disease. Our aims in this study were to reveal early gluten-induced transcriptomic changes in duodenal biopsies and to find tools for clinics.
METHODS
Duodenal biopsies were collected from 15 celiac disease patients on a strict long-term gluten-free diet (GFD) prior to and post a gluten challenge (PGC) and from 6 healthy control individuals (DC). Biopsy RNA was subjected to genome-wide 3' RNA-Seq. Sequencing data was used to determine the differences between the three groups and was compared to sequencing data from the public repositories. The biopsies underwent morphometric analyses.
RESULTS
In DC vs. GFD group comparisons, 167 differentially expressed genes were identified with 117 genes downregulated and 50 genes upregulated. In PGC vs. GFD group comparisons, 417 differentially expressed genes were identified with 195 genes downregulated and 222 genes upregulated. Celiac disease patients on a GFD were not "healthy". In particular, genes encoding proteins for transporting small molecules were expressed less. In addition to the activation of immune response genes, a gluten challenge induced hyperactive intestinal wnt-signaling and consequent immature crypt gene expression resulting in less differentiated epithelium. Biopsy gene expression in response to a gluten challenge correlated with the extent of the histological damage. Regression models using only four gene transcripts described 97.2% of the mucosal morphology and 98.0% of the inflammatory changes observed.
CONCLUSIONS
Our gluten challenge trial design provided an opportunity to study the transition from health to disease. The results show that even on a strict GFD, despite being deemed healthy, patients reveal patterns of ongoing disease. Here, a transcriptomic regression model estimating the extent of gluten-induced duodenal mucosal injury is presented.
Identifiants
pubmed: 32745639
pii: S2352-345X(20)30116-8
doi: 10.1016/j.jcmgh.2020.07.010
pmc: PMC7593586
pii:
doi:
Substances chimiques
Glutens
8002-80-0
Types de publication
Clinical Trial, Phase II
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13-32Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Références
Gastroenterology. 2017 Oct;153(4):924-935
pubmed: 28624578
Aliment Pharmacol Ther. 2007 Nov 1;26(9):1217-25
pubmed: 17944736
Am J Gastroenterol. 2004 May;99(5):894-904
pubmed: 15128357
J Exp Med. 2008 Jan 21;205(1):143-54
pubmed: 18166587
EBioMedicine. 2020 Jan;51:102567
pubmed: 31901853
N Engl J Med. 2007 Oct 25;357(17):1731-43
pubmed: 17960014
Nature. 2017 Nov 16;551(7680):333-339
pubmed: 29144463
PLoS One. 2015 Dec 09;10(12):e0144634
pubmed: 26649570
Sci Rep. 2019 May 7;9(1):7029
pubmed: 31065051
Ann Med. 2010 Dec;42(8):587-95
pubmed: 21070098
Sci Rep. 2019 Nov 7;9(1):16163
pubmed: 31700112
PLoS One. 2019 Apr 18;14(4):e0215132
pubmed: 30998704
Clin Nutr. 2016 Dec;35(6):1236-1241
pubmed: 27211234
Nutrients. 2020 Feb 15;12(2):
pubmed: 32075276
Clin Exp Immunol. 2002 Dec;130(3):526-31
pubmed: 12452845
J Gastroenterol Hepatol. 2019 Jan;34(1):169-177
pubmed: 29972865
Nutrients. 2019 Feb 01;11(2):
pubmed: 30717318
Am J Clin Nutr. 2012 Mar;95(3):670-7
pubmed: 22258271
Baillieres Clin Gastroenterol. 1995 Jun;9(2):231-49
pubmed: 7549026
Nature. 2020 Feb;578(7796):600-604
pubmed: 32051586
PLoS One. 2017 Sep 21;12(9):e0185025
pubmed: 28934294
Trends Mol Med. 2015 Aug;21(8):492-503
pubmed: 26144290
Clin Gastroenterol Hepatol. 2007 Jul;5(7):838-43
pubmed: 17544877
Cell Mol Life Sci. 2018 Dec;75(23):4385-4401
pubmed: 30097691
Am J Gastroenterol. 2016 Oct;111(10):1456-1465
pubmed: 27644734
Nutrients. 2019 Jan 15;11(1):
pubmed: 30650530
Cell Physiol Biochem. 2005;15(1-4):29-40
pubmed: 15665513
Mucosal Immunol. 2010 May;3(3):247-59
pubmed: 20404811
J Clin Pathol. 2012 Mar;65(3):242-7
pubmed: 22081783
Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-836.e2
pubmed: 29551598
Chemometr Intell Lab Syst. 2011 Dec 15;109(2):162-170
pubmed: 26246647
BMC Gastroenterol. 2019 Nov 15;19(1):189
pubmed: 31730447
Sci Rep. 2019 Feb 4;9(1):1298
pubmed: 30718669
Scand J Gastroenterol. 2011 May;46(5):538-49
pubmed: 21288140
Lancet Gastroenterol Hepatol. 2019 Dec;4(12):948-959
pubmed: 31494096
Nat Rev Immunol. 2013 Apr;13(4):294-302
pubmed: 23493116
Nat Genet. 2011 Nov 06;43(12):1193-201
pubmed: 22057235
Gastroenterology. 2009 Mar;136(3):816-23
pubmed: 19111551
Immunol Cell Biol. 2003 Aug;81(4):275-82
pubmed: 12848848
Nat Methods. 2014 Jan;11(1):106-12
pubmed: 24292484
PLoS One. 2011;6(12):e29094
pubmed: 22194996
Medicina (Kaunas). 2019 Jul 03;55(7):
pubmed: 31277328
Gastroenterology. 2014 Jun;146(7):1649-58
pubmed: 24583059
Scand J Gastroenterol. 2011 Sep;46(9):1065-73
pubmed: 21668407
Gastroenterology. 2020 Jan;158(1):151-159.e3
pubmed: 31560892
J Exp Med. 2020 Feb 3;217(2):
pubmed: 31727780
Scand J Gastroenterol. 2014 Nov;49(11):1318-24
pubmed: 25113634
Immunogenetics. 2020 Feb;72(1-2):85-88
pubmed: 31735991
BMC Gastroenterol. 2011 Nov 24;11:129
pubmed: 22115041
Am J Physiol Gastrointest Liver Physiol. 2008 Nov;295(5):G1122-30
pubmed: 18832447
J Transl Med. 2015 Jul 11;13:220
pubmed: 26160352
J Immunol. 2017 Apr 15;198(8):3005-3014
pubmed: 28373482
Cell Mol Gastroenterol Hepatol. 2017 Jan 28;4(1):1-17
pubmed: 28508029
Stem Cells. 2017 Feb;35(2):445-457
pubmed: 27570105
Clin Exp Immunol. 2007 Nov;150(2):294-305
pubmed: 17888028
Am J Gastroenterol. 2018 Mar;113(3):339-347
pubmed: 29460921
Curr Gastroenterol Rep. 2010 Oct;12(5):319-30
pubmed: 20703838
Am J Pathol. 2018 Jul;188(7):1563-1579
pubmed: 29684362
Gastroenterology. 2017 Sep;153(3):689-701.e1
pubmed: 28545781
Nutrients. 2019 Oct 08;11(10):
pubmed: 31597349
PLoS One. 2013 Oct 11;8(10):e76163
pubmed: 24146832
Gastroenterology. 2009 Dec;137(6):1912-33
pubmed: 19766641
Am J Clin Nutr. 2018 Feb 1;107(2):201-207
pubmed: 29529159
Am J Pathol. 2018 Jun;188(6):1354-1373
pubmed: 29545196